Atyr Pharma Inc (NASDAQ: ATYR) is 149.65% higher on its value in year-to-date trading and has touched a low of $1.08 and a high of $3.68 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ATYR stock was last observed hovering at around $3.49 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $3.52, the stock is 9.97% and 44.31% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.21 million and changing 0.86% at the moment leaves the stock 80.17% off its SMA200. ATYR registered 215.70% gain for a year compared to 6-month gain of 83.81%. The firm has a 50-day simple moving average (SMA 50) of $2.4042 and a 200-day simple moving average (SMA200) of $1.944125.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 28.00% loss in the last 1 month and extending the period to 3 months gives it a 76.00%, and is 8.31% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.06% over the week and 9.02% over the month.
Atyr Pharma Inc (ATYR) has around 59 employees, a market worth around $295.48M and $0.23M in sales. Profit margin for the company is -27155.74%. Distance from 52-week low is 225.90% and -4.35% from its 52-week high. The company has generated returns on investments over the last 12 months (-82.15%).
The EPS is expected to grow by 2.28% this year
The shares outstanding are 83.94M, and float is at 81.75M with Short Float at 2.03%.
Atyr Pharma Inc (ATYR) Insider Activity
The most recent transaction is an insider purchase by SCHIMMEL PAUL, the company’s Director. SEC filings show that SCHIMMEL PAUL bought 52,300 shares of the company’s common stock on Jul 24 ’24 at a price of $1.93 per share for a total of $0.1 million. Following the purchase, the insider now owns 0.41 million shares.
Atyr Pharma Inc disclosed in a document filed with the SEC on Jul 22 ’24 that SCHIMMEL PAUL (Director) bought a total of 41,052 shares of the company’s common stock. The trade occurred on Jul 22 ’24 and was made at $1.74 per share for $71500.0. Following the transaction, the insider now directly holds 0.35 million shares of the ATYR stock.
Still, SEC filings show that on Jul 23 ’24, SCHIMMEL PAUL (Director) acquired 6,648 shares at an average price of $1.82 for $12075.0. The insider now directly holds 360,723 shares of Atyr Pharma Inc (ATYR).
